138 related articles for article (PubMed ID: 16893081)
21. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
[TBL] [Abstract][Full Text] [Related]
22. Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
Kelly U; Yu L; Kumar P; Ding JD; Jiang H; Hageman GS; Arshavsky VY; Frank MM; Hauser MA; Rickman CB
J Immunol; 2010 Nov; 185(9):5486-94. PubMed ID: 20876352
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.
Sánchez-Corral P; González-Rubio C; Rodríguez de Córdoba S; López-Trascasa M
Mol Immunol; 2004 May; 41(1):81-4. PubMed ID: 15140578
[TBL] [Abstract][Full Text] [Related]
24. Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.
Hyvärinen S; Uchida K; Varjosalo M; Jokela R; Jokiranta TS
J Biol Chem; 2014 Feb; 289(7):4295-306. PubMed ID: 24344133
[TBL] [Abstract][Full Text] [Related]
25. Complement factor H and hemolytic uremic syndrome.
Zipfel PF; Skerka C; Caprioli J; Manuelian T; Neumann HH; Noris M; Remuzzi G
Int Immunopharmacol; 2001 Mar; 1(3):461-8. PubMed ID: 11367530
[TBL] [Abstract][Full Text] [Related]
26. Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits.
Meri S; Haapasalo K
Front Immunol; 2020; 11():611830. PubMed ID: 33363547
[TBL] [Abstract][Full Text] [Related]
27. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
28. Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.
Pelicano MB; de Córdoba SR; Diekmann F; Saiz M; Herrero S; Oppenheimer F; Campistol JM
Transplantation; 2013 Aug; 96(4):e26-9. PubMed ID: 23958887
[No Abstract] [Full Text] [Related]
29. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.
Zimmerhackl LB; Hofer J; Cortina G; Mark W; Würzner R; Jungraithmayr TC; Khursigara G; Kliche KO; Radauer W
N Engl J Med; 2010 May; 362(18):1746-8. PubMed ID: 20445192
[No Abstract] [Full Text] [Related]
30. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
31. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
32. Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure.
Herbert AP; Uhrín D; Lyon M; Pangburn MK; Barlow PN
J Biol Chem; 2006 Jun; 281(24):16512-20. PubMed ID: 16533809
[TBL] [Abstract][Full Text] [Related]
33. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
Richards A; Kavanagh D; Atkinson JP
Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
[TBL] [Abstract][Full Text] [Related]
34. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.
Skerka C; Lauer N; Weinberger AA; Keilhauer CN; Sühnel J; Smith R; Schlötzer-Schrehardt U; Fritsche L; Heinen S; Hartmann A; Weber BH; Zipfel PF
Mol Immunol; 2007 Jul; 44(13):3398-406. PubMed ID: 17399790
[TBL] [Abstract][Full Text] [Related]
35. Complement and diseases: defective alternative pathway control results in kidney and eye diseases.
Zipfel PF; Heinen S; Józsi M; Skerka C
Mol Immunol; 2006 Jan; 43(1-2):97-106. PubMed ID: 16026839
[TBL] [Abstract][Full Text] [Related]
36. The effect of electrostatics on factor H function and related pathologies.
Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
[TBL] [Abstract][Full Text] [Related]
37. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
[TBL] [Abstract][Full Text] [Related]
38. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.
Herbert AP; Deakin JA; Schmidt CQ; Blaum BS; Egan C; Ferreira VP; Pangburn MK; Lyon M; Uhrín D; Barlow PN
J Biol Chem; 2007 Jun; 282(26):18960-8. PubMed ID: 17360715
[TBL] [Abstract][Full Text] [Related]
39. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.
Caprioli J; Bettinaglio P; Zipfel PF; Amadei B; Daina E; Gamba S; Skerka C; Marziliano N; Remuzzi G; Noris M
J Am Soc Nephrol; 2001 Feb; 12(2):297-307. PubMed ID: 11158219
[TBL] [Abstract][Full Text] [Related]
40. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
Józsi M; Strobel S; Dahse HM; Liu WS; Hoyer PF; Oppermann M; Skerka C; Zipfel PF
Blood; 2007 Sep; 110(5):1516-8. PubMed ID: 17495132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
